Campylobacter coli cultured from the stools of a patient with immunoproliferative small intestinal disease

Autor: Coeuret, S., de La Blanchardière, A., Saguet-Rysanek, V., Chèze, S., Tavernier, M., Arsène, D., Criscuolo, A., Brisse, S., Vergnaud, M., Verdon, R., Lecuit, M.

Publikováno v: In Clinical Microbiology and Infection September 2014 20(9):908-911

Thyroid 18F-fluorocholine uptake in patients with chronic autoimmune thyroiditis.

Autor: Ciappuccini R; Department of Nuclear Medicine and Thyroid Unit, François Baclesse Cancer Centre, Caen, France.; INSERM 1086 ANTICIPE, Caen University, Caen, France., Saguet-Rysanek V; Department of Pathology, François Baclesse Cancer Centre, Caen, France., Dorbeau M; Department of Pathology, François Baclesse Cancer Centre, Caen, France., Lequesne J; Department of Clinical Research, François Baclesse Cancer Centre, Caen, France., Linard C; Department of Pathology, François Baclesse Cancer Centre, Caen, France., Lefevre-Arbogast S; Department of Clinical Research, François Baclesse Cancer Centre, Caen, France., Clarisse B; Department of Clinical Research, François Baclesse Cancer Centre, Caen, France., Bardet S; Department of Nuclear Medicine and Thyroid Unit, François Baclesse Cancer Centre, Caen, France.

Publikováno v: European thyroid journal [Eur Thyroid J] 2022 Jun 21; Vol. 11 (3). Date of Electronic Publication: 2022 Jun 21.

PSMA Expression in Differentiated Thyroid Cancer: Association With Radioiodine, 18FDG Uptake, and Patient Outcome.

Autor: Ciappuccini R; Department of Nuclear Medicine and Thyroid Unit, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France.; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), 14000 Caen, France., Saguet-Rysanek V; Department of Pathology, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Giffard F; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), 14000 Caen, France.; UNICANCER, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Licaj I; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), 14000 Caen, France.; Department of Clinical Research, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France.; Department of Community Medicine, Faculty of Health Sciences, The UiT Arctic University of Norway, 9010 Tromsø, Norway., Dorbeau M; Department of Pathology, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Clarisse B; Department of Clinical Research, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Poulain L; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), 14000 Caen, France.; UNICANCER, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Bardet S; Department of Nuclear Medicine and Thyroid Unit, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2021 Nov 19; Vol. 106 (12), pp. 3536-3545.

Potential application of [¹⁸F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma.

Autor: Van den Broeck, Bliede¹ (AUTHOR) bliede.vandenbroeck@uzgent.be, Debacker, Jens M.^2,3,4 (AUTHOR), Bauters, Wouter⁵ (AUTHOR), Creytens, David^6,7 (AUTHOR), Ferdinande, Liesbeth^6,7 (AUTHOR), Huvenne, Wouter^4,8 (AUTHOR), Lapauw, Bruno^9,10 (AUTHOR), Schelfhout, Vanessa^7,11 (AUTHOR), Van Laeken, Nick¹ (AUTHOR), Verroken, Charlotte⁹ (AUTHOR)

Publikováno v: EJNMMI Research. 9/12/2024, Vol. 14 Issue 1, p1-10. 10p.

Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome.

Autor: Ciappuccini R; Department of Nuclear Medicine and Thyroid Unit, François Baclesse Cancer Centre, 3 Avenue Général Harris, F-14000, Caen, France. r.ciappuccini@baclesse.unicancer.fr.; INSERM 1086 ANTICIPE, Caen University, Caen, France. r.ciappuccini@baclesse.unicancer.fr., Heutte N; CETAPS EA 3832, Rouen University, Rouen, France., Lasne-Cardon A; Department of Head and Neck Surgery, François Baclesse Cancer Centre, Caen, France., Saguet-Rysanek V; Department of Pathology, François Baclesse Cancer Centre, Caen, France., Leroy C; Department of Oncology, François Baclesse Cancer Centre, Caen, France., Le Hénaff V; Department of Nuclear Medicine and Thyroid Unit, François Baclesse Cancer Centre, 3 Avenue Général Harris, F-14000, Caen, France., Vaur D; Department of Cancer Biology and Genetics, François Baclesse Cancer Centre, Caen, France., Babin E; INSERM 1086 ANTICIPE, Caen University, Caen, France.; Department of Head and Neck Surgery, François Baclesse Cancer Centre, Caen, France.; Department of Head and Neck Surgery, University Hospital, Caen, France., Bardet S; Department of Nuclear Medicine and Thyroid Unit, François Baclesse Cancer Centre, 3 Avenue Général Harris, F-14000, Caen, France.

Publikováno v: BMC cancer [BMC Cancer] 2020 Aug 14; Vol. 20 (1), pp. 765. Date of Electronic Publication: 2020 Aug 14.